1,392
Views
17
CrossRef citations to date
0
Altmetric
Non-themed Articles

Statistical comparison of dissolution profiles

, , &
Pages 796-807 | Received 12 Jan 2015, Accepted 24 Jul 2015, Published online: 20 Aug 2015

References

  • FDA. Guidance for Industry: Modified Release Solid Oral Dosage Forms: Scale-up and Post Approval Changes (SUPAC-MR): Chemistry, Manufacturing and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation. 1997
  • FDA. Guidance for Industry: Extended Release Oral Dosage Forms- Development, Evaluation, and Application of In Vitro/In Vivo Correlations. 1997
  • FDA. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. 1997
  • Yuksel N, Kanik AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and-independent methods. Int J Pharm 2000;209:57–67
  • Van Vooren L, Krikilion G, Rosier J, De Spiegeleer B. A novel bending point criterion for dissolution profile interpretation. Drug Dev Ind Pharm 2001;27:885–92
  • Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles. Pharm Technol 1996;20:64–74
  • Peh KK, Wong CF. Application of similarity factor in development of controlled-release diltiazem tablet. Drug Dev Ind Pharm 2000;26:723–30
  • Williams RO, Reynolds TD, Cabelka TD, et al. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC. Pharm Dev Technol 2002;7:181–93
  • Zhang X, Tang X, Yang R. Development of a Tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets. Drug Dev Ind Pharm 2009;35:26–33
  • Kim H. Esbensen aPP-M. Process sampling: theory of sampling-the missing link in process analytical technologies (PAT). In: Bakeev KA, ed. Process analytical technology: spectroscopic tools and implementation strategies for the chemical and pharmaceutical industries. 2nd edn. New York (NY): John Wiley and Sons; 2010
  • Stevens RE, Gray V, Dorantes A, et al. Scientific and regulatory standards for assessing product performance using the similarity factor, f2. AAPS J 2015;17:301–6
  • Maggio RM, Rivero MA, Kaufman TS. Simultaneous acquisition of the dissolution curves of two active ingredients in a binary pharmaceutical association, employing an on-line circulation system and chemometrics-assistance. J Pharm Biomed Anal 2013;72:51–8
  • Montgomery DC. Design and analysis of experiments. 8th edn. New York (NY): Wiley Global Education; 2012
  • Liu J-P, Ma M-C, Chow S-C. Statistical evaluation of similarity factor f2 as a criterion for assessment of similarity between dissolution profiles. Drug Inf J 1997;31:1255–71
  • Hsu JY, Hsu MY, Liao CC, Hsu HC. On the characteristics of the FDA's similarity factor for comparison of drug dissolution. J Food Drug Anal 1998;6:553–8
  • Shah VP, Tsong Y, Sathe P, Liu JP. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f(2). Pharm Res 1998;15:889–96
  • Ma MC, Lin RP, Liu JP. Statistical evaluations of dissolution similarity. Stat Sin 1999;9:1011–27
  • Ocana J, Frutos G, Sanchez P. Using the similarity factor f(2) in practice: a critical revision and suggestions for its standard error estimation. Chemometr Intell Lab 2009;99:49–56
  • Gohel MC, Panchal MK. Novel use of similarity factors f2 and Sd for the development of Diltiazem HCl modified-release tablets using a 32 factorial design. Drug Dev Ind Pharm 2002;28:77–87
  • Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm 2005;31:25–34
  • Seo PR, Shah VP, Polli JE. Novel metrics to compare dissolution profiles. Pharm Dev Technol 2002;7:257–65
  • Saranadasa H, Krishnamoorthy K. A multivariate test for similarity of two dissolution profiles. J Biopharm Stat 2005;15:265–78
  • Maggio RM, Castellano PM, Kaufman TS. A new principal component analysis-based approach for testing “similarity” of drug dissolution profiles. Eur J Pharm Sci 2008;34:66–77
  • Maggio RM, Castellano PM, Kaufman TS. PCA-CR analysis of dissolution profiles. A chemometric approach to probe the polymorphic form of the active pharmaceutical ingredient in a drug product. Int J Pharm 2009;378:187–93
  • Tsong Y, Hammerstrom T, Chen JJ. Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis. J Biopharm Stat 1997;7:423–39
  • Adams E, De Maesschalck R, De Spiegeleer B, et al. Evaluation of dissolution profiles using principal component analysis. Int J Pharm 2001;212:41–53
  • Adams E, Walczak B, Vervaet C, et al. Principal component analysis of dissolution data with missing elements. Int J Pharm 2002;234:169–78
  • Gómez-Mantilla J-D, Casabó VG, Schaefer UF, Lehr C-M. Permutation Test (PT) and Tolerated Difference Test (TDT): two new, robust and powerful nonparametric tests for statistical comparison of dissolution profiles. Int J Pharm 2013;441:458–67
  • Enachescu D. Exploratory data analysis methods for comparison of drug dissolution profiles. Biocybern Biomed Eng 2010;30:17–27
  • Chow SC, Shao J. On the assessment of similarity for dissolution profiles of two drug products. J Biopharm Stat 2002;12:311–21
  • Lansky P, Weiss M. Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity. J Pharm Sci 2003;92:1632–47
  • Berry MR, Likar MD. Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach. J Pharm Biomed Anal 2007;45:194–200
  • Gill J. Repeated measurement: split-plot trend analysis versus analysis of first differences. Biometrics 1988;44:289–97
  • Raudenbush SW. Hierarchical linear models and experimental design. In: Edwards L, ed. Applied analysis of variance in behavioral science. New York: CRC Press; 1993:459–94
  • Timm NH. Multivariate analysis of variance of repeated measurements. In: Krishnaiah PR, ed. Handbook of statistics. Amsterdam: North-Holland; 1980:186–282
  • Weinfurt KP. Repeated measures analysis: ANOVA, MANOVA, and HLM. In: Yarnold LGGPR, ed. Reading and understanding MORE multivariate statistics. Washington, DC: American Psychological Association; 2000:317–61
  • O'Brien RG, Kaiser MK. MANOVA method for analyzing repeated measures designs: an extensive primer. US: American Psychological Association; 1985:316–33
  • Snee RD. On the analysis of response curve data. Technometrics 1972;14:47–62
  • Gollob HF. Confounding of sources of variation in factor-analytic techniques. Psychol Bull 1968;70:330–44
  • Olejnik S, Algina J. Generalized eta and omega squared statistics: measures of effect size for some common research designs. Psychol Methods 2003;8:434–47
  • Geoffrey Keppel TDW. Effect size, power, and sample size. Design and analysis: a researcher's handbook. Englewood Cliffs (NJ): Prentice-Hall; 2004
  • Mauger JW, Chilko D, Howard S. On the analysis of dissolution data. Drug Dev Ind Pharm 1986;12:969–92
  • Cohen J. Statistical power analysis for the behavior sciences. Hillsdale (NJ): Lawrenced Erlbaum Associates, Inc.; 1988:283–6
  • Hsu JC, Peruggia M. Graphical representations of Tukey's Multiple Comparison Method. J Comput Graph Stat 1994;3:143–61

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.